Read + Share
Amedeo Smart
Independent Medical Education
Handa S, Lee JO, Derkach A, Stone RM, et al. Long Term Outcomes in Patients with Relapsed or Refractory Hairy Cell Leukemia Treated with Vemurafenib Monotherapy. Blood 2022 Aug 5. pii: 486128. doi: 10.1182/blood.2022016183.PMID: 35930750
Email
LinkedIn
Facebook
Twitter
Privacy Policy